Treatment of CLL cells with Th T-cell-derived factors, such as IFNγ [44], IL-21 [23], IL-4 [45], CD40L [18, 23, 45], or their combinations, either reduced apoptosis or induced proliferation of CLL cells in vitro (Table 1). This evidence concerns the gene IFNG and B-cell chronic lymphocytic leukemia.